Aspire Biopharma Holdings ASBP
NASDAQ ASBP
$8.74 +0.02 (+0.23%)
As of: Oct 21, 2026 · 1:06 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Short term Debt (2023 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Short term Debt of $499,214 in Q1 2026, down 84.3% from $3.18 million a year earlier and down 66.7% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Short term Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, Aspire Biopharma Holdings reported Short term Debt of $1.5 million, down 89.1% from FY2024.

  • Across earlier years, Short term Debt came in at $13.76 million in FY2024 and $12,384 in FY2023.
  • The Q1 2026 figure is the lowest quarterly Short term Debt since Q1 2024.
  • On a year-over-year basis, Short term Debt has declined for four consecutive quarters, with an average decline of 50.8% over the last four quarters.
  • Per Business Quant, the preceding three quarters came in at $1.5 million (Q4 2025), $4.74 million (Q3 2025) and $3.62 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 499,214.00
Dec 31, 2025 2.79 Mn
Sep 30, 2025 6.24 Mn
Jun 30, 2025 6.14 Mn
Mar 31, 2025 5.55 Mn
Dec 31, 2024 14.23 Mn
Sep 30, 2024 4.90 Mn
Jun 30, 2024 5.36 Mn
Mar 31, 2024 217,232.00
Dec 31, 2023 12,384.00
API Access

Aspire Biopharma Holdings, Inc. Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ASBP&period=max&api_key=YOUR_API_KEY